March 21, 2013

Severe weather in Nashville March 18 prompted the sounding of Metropolitan Nashville's sirens and also prompted some questions about Vanderbilt's notification system. Read more...

Breast cancer study explores therapy to slow recurrence


Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer. A new study by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests drugs that block or inhibit the TGF-b signaling pathway in cancer cells enhance the effect of chemotherapy and may prevent recurrences of treatment-resistant TNBC. Read more...

Whitsett set for Flexner Discovery Lecture, Thursday, March 28


Jeffrey Whitsett, M.D., chief of the Section of Neonatology, Perinatal and Pulmonary Biology at Cincinnati Children's Hospital Medical Center, will deliver the next Flexner Discovery Lecture on Thursday, March 28. Read more...

Patient's cancer journey inspires fund for research


There's a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine. Read more...